Astrazeneca Pharma India standalone net profit declines 21.16% in the December 2020 quarter
Sales decline 10.55% to Rs 200.25 crore
Net profit of Astrazeneca Pharma India declined 21.16% to Rs 21.05 crore in the quarter ended December 2020 as against Rs 26.70 crore during the previous quarter ended December 2019. Sales declined 10.55% to Rs 200.25 crore in the quarter ended December 2020 as against Rs 223.86 crore during the previous quarter ended December 2019. ParticularsQuarter EndedDec. 2020Dec. 2019% Var.Sales200.25223.86 -11 OPM %15.3516.42 -PBDT33.4139.95 -16 PBT28.3035.18 -20 NP21.0526.70 -21Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 09 2021 | 9:45 AM IST